FEAM calls for the Hungarian Government to continue supporting research excellence in Hungary by maintaining the current infrastructure, funding and scientific independence of the Hungarian Academy of Sciences and its network of institutes. While Orbán’s Government’s intention to strengthen innovation in Hungary is welcome, its proposed changes to national legislation affecting the Hungarian Academy of […]
Professor George Griffin, President of FEAM, commented the recent Nature paper release describing the effect of Stem Cell transplantation on HIV infection: https://www.bbc.com/news/health-47421855 “This report is very important in understanding the basic and clinical pathophysiology of HIV infection. Clearly bone marrow transplantation is not the major therapeutic aim particularly given the efficiency of antiretroviral therapy. However, […]
Final Program Online Registration Form
Follow the latest news from FEAM! Newsletter, February 2019
About the Annual Lecture Important discussions are currently ongoing on the potential application of the artificial intelligence (AI) in healthcare sector. In this regard, European authorities have been discussing for a while the opportunity of using AI for managing, interpreting and monitoring medical data to identify recommendation for a proper and correct use of […]
Summary report now available: EASAC/FEAM Workshop on Vaccination – Scientific and social perspectives, 22 October 2018, Amsterdam On 22 October 2018, European Academies Advisory Council (EASAC) and FEAM organised a workshop on the scientific and social perspectives of vaccination, hosted by the Royal Netherlands Academy of Arts and Sciences (KNAW). The event was moderated by Prof. George Griffin, President of […]
Summary report of a workshop discussion held on 19 November 2018, Palais des Academies, Brussels On the 19th November 2018, a workshop discussion organized by the Federation of European Academies of Medicine (FEAM), defined the policy interventions and the medical actions to be taken by the European Commission and Member States to ensure the correct functioning […]
The best available evidence suggests that microplastics and nanoplastics do not pose a widespread risk to humans or the environment, except in small pockets. But that evidence is limited, and the situation could change if pollution continues at the current rate. This is the verdict of SAPEA’s Evidence Review Report on micro- and nanoplastic pollution, […]
Following the successful 2016 Spring Conference of the Federation of European Academies of Medicine (FEAM), hosted by the Swiss Academy of Medical Sciences (SAMS), the second European Conference on Precision Medicine and Personalized Health will be held at Campus Biotech in Geneva, Switzerland, on 28 September 2018. The conference provides an ideal opportunity to hear […]
FEAM Forum / Personalised medicine
On 24 May 2018, the All European Academies (ALLEA) and FEAM organised a symposium on health inequalities, under the leadership of a joint interdisciplinary Scientific Committee, and hosted by the Royal Netherlands Academy of Arts and Sciences (KNAW) in Amsterdam. It was chaired by Professor George Griffin, President of FEAM, and Professor Johan Mackenbach, Fellow […]
FEAM puts forward several recommendations to improve the Horizon Europe proposals and the environment for biomedical and health research in Europe.
FEAM reiterates its commitment to the One Health concept by supporting the Romanian Academy of Medical Sciences in contributing to the development of a dedicated National Center of Excellence in Romania. More activities to follow in 2019! Summary report – FEAM One Health Conference (RAMS, Bucharest, 2014) FEAM-IAP Health Declaration on One Health (2014) […]
FEAM calls the UK and other EU member states for continued medical research cooperation post Brexit with a special focus on mobility of researchers, driving excellence and forging international collaboration, and safeguarding patients’interests. Download the statement
Brexit / Research
Prof. George Griffin attends EC Expert panel on Effective ways of investing in health’s hearing on Vaccination programmes and health systems in Europe. Watch the webstreaming here.
FEAM is recruiting two Policy Officers to oversee the development of the FEAM policy programme and European Biomedical Policy Forum Senior Scientific Policy Officer Monthly gross salary: 4 500 EUR, plus additional employment benefits consistent with the Belgian location. Details about the position and application are available here. Deadline for application: 1 October 2018 […]
FEAM is recruiting a full-time Project Assistant to support the management and coordination of work in the EU-funded SAPEA project. Monthly gross salary: 2 500 EUR, plus additional employment benefits consistent with the Belgian location. Deadline for application: September 9. Details about the position and application are available here.
The Federation of European Academies of Medicine (FEAM) welcomes the publication of Horizon Europe, the next EU Framework Programme for Research and Innovation. FEAM welcomes the increased budget of €100 billion for 2021-2027. This is a positive sign of the European Commission’s commitment to put strong focus on research and the EU at the forefront […]
The European population is ageing rapidly and life expectancy continues to increase. Europe needs to ensure that the increasing numbers of elderly people can spend those extra years of life in good health, with adequate functional ability, and opportunities to contribute to society. To ensure healthy ageing of the European population, a broad range of […]
Ageing / SAPEA
As an initiative from SAPEA (Science Advice for Policy by European Academies), the Scientific Advice Mechanism is taking up the task of providing science advice to the European Commission on the future of ageing. This will take account of the current international and European policy context and the available scientific evidence, to address the question of […]
Ageing / SAPEA
SAPEA (Science Advice for Policy by European Academies) has published its third Evidence Review Report titled Improving authorisation processes for plant protection products in Europe: a scientific perspective on the assessment of potential risks to human health. The report examines the methods and procedures for assessing potential harmful effects on human health from the use of Plant […]